GSK PLC (GS71.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR

Add to watchlist

18.61

-0.31

(-1.64%)

At close: 07:32PM CEST

All

Business Wire
US FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk
PHILADELPHIA, June 07, 2024--US FDA approves expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk
Simply Wall St.
The total return for GSK (LON:GSK) investors has risen faster than earnings growth over the last year
The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better...
Evening Standard
FTSE 100 Live 3 June: New York trading glitch sparks volatility, GSK shares tumble
GSK shares are today’s major focus after the drugs giant’s defence against Zantac claims suffered a setback in a Delaware court. The FTSE 100 index is trading higher after Friday’s late rally by Wall Street markets was further boosted by this week’s prospect of an ECB interest rate cut. Other companies in the spotlight today include FTSE 250-listed Hollywood Bowl, having posted an 11% rise in half-year profits.